Results 201 to 210 of about 3,439,907 (351)

Prevalence of medical writing in hematological malignancy review articles. [PDF]

BMC Cancer
Vaquera-Alfaro HA, Nasrollahi E, Mangala YO, Russler-Germain D, Goodman A, Mohyuddin GR.   +5 more
europepmc   +1 more source

Hedging in Medical and Pharmaceutical Academic Writing

Aseel Alshbeekat
openalex   +2 more sources

Interrogating the immune landscape of microsatellite stable RAS‐mutated colon cancer

Molecular Oncology, EarlyView.
COLOSSUS project RAS‐mutated MSS colon cancer study explored transcriptomics and immune cell density by immunohistochemistry (IHC), Immunoscore (IS), ISIC/TuLIS scores, mutation counts, and detected different prevalences but similar microenvironment composition across immune markers with clinical relevance for future immunotherapy combination ...
Rodrigo Dienstmann, Eduardo García‐Galea, Alice O'Farrell, Zak Kinsella, Maxime Meylan, Florent Petitprez, Ingrid Arijs, Tom Venken, Hari Ps, Adrian Lärkeryd, Ian Miller, Janick Selves, Nadja Meindl‐Beinker, Fiorella Ruiz‐Pace, Elena Élez, Raquel Comas‐Navarro, Frank Lincoln, Dirk Fey, Gift Nyamundanda, Aoife Nolan, Joern Lewin, Raquel Perez‐Lopez, Jonathan Briody, Kathleen Bennett, Walter Kolch, David Matallanas, Alexander Kel, Enrique Arenas, Joaquín Arribas, Bart Ghesquière, Josep Tabernero, Julie Meilleroux, Deborah McNamara, Ray McDermott, Marvin Lim, Mary O'Reilly, Brian Bird, Lisa Stack, Lucia Moloney, Patrick Morris, Keith Egan, Maciej Milewski, Lars Scheuer, Joachim Behringer, Georg Bolz, Ramon Salazar, Cristina Santos, Andrea Ruiz, Orla Casey, Verena Murphy, Matthias Ebert, Livio Trusolino, Diether Lambrechts, Anguraj Sadanandam, Catherine Sautès‐Fridman, Jochen Prehn, Paolo Nuciforo, Jacques Fieschi, Florence Monville, Darran O'Connor, Wolf Fridman, Annette Byrne   +61 more
wiley   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

Molecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla, Christopher Dirks, Caroline Eiden, Sonja K. Fesenmayer, Femke M. Hormann, Yolande Klootsema, Ingrid Lilienthal, Si Min Zhang, Nikolas Herold, Sean G. Rudd   +9 more
wiley   +1 more source

Artificial Intelligence in Medical Writing: Decide its Use or Non-Use Based on Long-Span Merits. [PDF]

Ann Card Anaesth
Matsubara S.
europepmc   +1 more source

A String of Pearls: Lessons for Medical Writing and Submitting for Publication. [PDF]

PRiMER, 2020
Ledford CJW.
europepmc   +1 more source

Publication in Medical Education Scientific Area: A Challenging Journey in Disseminating Scientific Writing in Health Profession Education

Hikmawati Nurrokhmanti, Luthfi Saiful Arif, Silvia Mustika Sari, Widyandana Widyandana, Mora Claramita   +4 more
openalex   +2 more sources

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch, Isabel Vogel, Sina Nokodian, Johanna Moeller, Antonia Blechschmidt, Vicky Hecht, Vanessa Kuentzel, Katharina Thiedig, Melissa Schwab, Oliver Schilling, Holger Bronger, Marion Kiechle, Viktor Magdolen, Tobias Dreyer   +13 more
wiley   +1 more source

Use of a Social Media Platform for Undergraduate Medical Writing: Experience From a Developing Country. [PDF]

Cureus
Serasinghe S, Geekiyanage U, Premaratne B, Siriwardana R.   +3 more
europepmc   +1 more source

The Write Stuff: The Development of a Medical Writing Pharmacy Residency Elective. [PDF]

Innov Pharm, 2020
Frederick EK, Palmer EC, O'Reilly EA, Kuszmaul AK, Spencer C.   +4 more
europepmc   +1 more source